SCHEMBL19082040

SCHEMBL19082040

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)sc5c6ccc6oc7ccc8ccccc8c7c65)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
PRKDC P78527 1/20 0.36
LIMK1 P53667 2/20 0.35
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
AHR P35869 3/20 0.33
PAX8 Q06710 2/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081785 0.94 ALOX5 (0.36) ALOX5PRKDCLIMK1MEN1MAPT
SCHEMBL19081931 0.92 ALOX5 (0.34) ALOX5PRKDCLIMK1MEN1MAPT
SCHEMBL19082034 0.92 ALOX5 (0.37) ALOX5PRKDCMEN1MAPTKMT2A
SCHEMBL19081858 0.90 ABCG2 (0.38) LIMK1MEN1MAPTKMT2AALDH1A1
SCHEMBL19082359 0.86 ALOX5 (0.39) ALOX5PRKDCLIMK1CYP1A1CYP1A2
SCHEMBL17944391 0.86 ALOX5 (0.44) ALOX5PRKDCLIMK1CYP1A1CYP1A2
SCHEMBL19082033 0.86 AHR (0.33) ALOX5PRKDCMEN1MAPTKMT2A
SCHEMBL24343120 0.85 ALOX5 (0.35) ALOX5PRKDCABCG2TDP1MCL1
SCHEMBL19076802 0.85 ALOX5 (0.40) ALOX5PRKDCMEN1MAPTKMT2A
SCHEMBL19076797 0.84 TDP1 (0.33) ALOX5PRKDCLIMK1TDP1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885PRKDC 4719/4885LIMK1 440/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885PRKDC 4719/4885LIMK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.